Stem Cell Therapy for Crohn's Disease in Thailand
An immunomodulatory approach to managing chronic intestinal inflammation
Understanding Crohn's Disease
Crohn's disease is a chronic inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract, most commonly the terminal ileum and colon. The condition is driven by a dysregulated immune response against intestinal microbiota in genetically susceptible individuals, resulting in transmural inflammation, strictures, fistulae, and progressive bowel damage. Conventional treatments including aminosalicylates, corticosteroids, immunomodulators, and biologic agents aim to induce and maintain remission, but many patients experience refractory disease or intolerable side effects. Mesenchymal stem cells have demonstrated significant anti-inflammatory and tissue-reparative properties in clinical trials for Crohn's disease, including European Medicines Agency-approved applications for perianal fistulae. Treatment is delivered at Boston Health Longevity in Chiang Mai with careful gastroenterological assessment and evidence-informed protocols.
Patients from Australia, Singapore, Hong Kong, and the UAE travel to Chiang Mai for treatment at Boston Health Longevity, accessing advanced UC-MSC treatments often unavailable in their home countries at internationally competitive pricing.
What Causes Crohn's Disease?
Genetic susceptibility plays a significant role, with over 200 gene loci associated with inflammatory bowel disease. Variants in the NOD2/CARD15 gene are among the strongest risk factors, affecting how the immune system recognises and responds to intestinal bacteria.
Dysregulated immune response to the gut microbiome is the central disease mechanism. In genetically predisposed individuals, the mucosal immune system mounts an inappropriate inflammatory reaction against normal intestinal bacteria, driving chronic transmural inflammation.
Alterations in the intestinal microbiome (dysbiosis) contribute to disease initiation and perpetuation. Reduced microbial diversity and shifts in bacterial populations may impair intestinal barrier function and trigger immune activation.
Environmental factors including smoking (the strongest modifiable risk factor for Crohn's), Western-style diet high in processed foods, antibiotic exposure, and urbanisation are associated with increased disease risk and may alter immune-microbial interactions.
Defects in the intestinal epithelial barrier allow bacterial translocation into deeper tissue layers, activating the mucosal immune system and perpetuating the cycle of inflammation, tissue damage, and impaired healing.
Common Signs and Symptoms
Chronic abdominal pain, often in the right lower quadrant, ranging from dull cramping to severe episodes. Pain may be associated with meals and can become constant during active flares.
Persistent diarrhoea, which may contain blood and mucus, occurring multiple times daily. Urgency and nocturnal symptoms are common during active disease and can be profoundly disabling.
Unintentional weight loss and malnutrition resulting from reduced food intake (patients learn to avoid eating to prevent pain), malabsorption from inflamed intestinal lining, and increased metabolic demand from chronic inflammation.
Profound fatigue that extends beyond tiredness, driven by chronic inflammation, anaemia (from blood loss and poor iron absorption), and the overall metabolic burden of active disease.
Perianal disease including fistulae, abscesses, fissures, and skin tags, affecting up to 40% of patients. These complications cause significant pain, discharge, and embarrassment.
Extraintestinal manifestations including joint inflammation (arthritis), eye inflammation (uveitis), skin conditions (erythema nodosum, pyoderma gangrenosum), and liver involvement (primary sclerosing cholangitis).
Intestinal complications including strictures (narrowing) causing obstruction, fistulae (abnormal connections between bowel loops or to skin), and abscess formation requiring surgical intervention.
Living With Crohn's Disease
Living with Crohn's disease means your life revolves around unpredictability. You may map every outing by proximity to toilets, decline social invitations because you cannot guarantee you will be well enough to attend, and live in fear of the next flare that could land you in hospital. The disease can rob you of your ability to eat normally, leaving you malnourished, exhausted, and unable to enjoy meals with family. Many patients describe the isolation of living with a condition that others cannot see but that dominates every aspect of daily life. The prospect of repeated surgeries, the indignity of perianal complications, and the side effects of powerful medications create a burden that extends far beyond the gut. If you are reading this, you likely understand the relentless nature of this disease and the desire for an approach that addresses more than just symptoms.
Conventional Treatment Options
Standard Crohn's disease management follows a step-up approach: aminosalicylates for mild disease, corticosteroids for flare induction, immunomodulators (azathioprine, methotrexate) for maintenance, and biologic therapies (anti-TNF agents like infliximab and adalimumab, vedolizumab, ustekinumab) for moderate to severe disease. While biologics have transformed outcomes for many patients, up to 40% do not respond to initial biologic therapy, and many who do respond experience secondary loss of response over time. Approximately 50% of Crohn's patients require surgery within 10 years of diagnosis, and disease recurrence after surgery is common. Long-term immunosuppression carries risks of serious infection, lymphoma, and other malignancies. The reality of cycling through medications, enduring side effects, and facing repeated surgical interventions drives many patients to explore complementary approaches.
If you have exhausted conventional options or are looking for alternatives to surgery, stem cell therapy may offer a different path. Discuss your situation with our clinical team.
Is It Right For You?
Good Candidates
Patients with moderate to severe Crohn's disease who have not achieved adequate remission with conventional therapies, or who experience frequent relapses despite standard treatment, may be candidates. Those with steroid-dependent disease seeking to reduce corticosteroid burden, or patients who have experienced adverse effects from biologic therapies, should be assessed. A comprehensive gastroenterological evaluation including recent endoscopy, imaging, and inflammatory markers is required.
Contraindications
Clinical outcomes for crohn's disease
Based on published peer-reviewed studies, clinical registry data, and patient-reported outcomes from mesenchymal stem cell (MSC) therapy programmes worldwide.
64%
Symptom Reduction
Average improvement in disease activity scores across autoimmune conditions treated
52%
Medication Reduction
Patients able to reduce immunosuppressive medication with physician guidance
3-6 mo
Response Timeline
Typical period for immune modulation effects to become clinically measurable
78%
Flare Reduction
Patients reporting fewer or less severe disease flares in 12-month follow-up
Individual results vary. Outcomes are drawn from published clinical literature and may not reflect every patient's experience. Learn about our evidence standards.
How Stem Cell Therapy May Help
Why Patients Choose Thailand for Crohn's Disease Treatment
Umbilical cord-derived MSC therapy for Crohn's disease is not commercially available in most Western countries due to regulatory restrictions. In Australia (TGA), the UK (MHRA), Singapore (HSA), and much of Europe, these treatments remain classified as investigational. Thailand provides a regulated framework for responsible provision of advanced immunomodulatory therapies.
Boston Health Longevity uses GMP-certified UC-MSCs (Wharton's Jelly) with full certificates of analysis, ensuring cell viability, sterility, and consistent dosage. Every treatment protocol is designed and directed by Dr Michael Ackland, MBBS (Hons), FRACGP, with over 40 years of clinical experience.
Transparent pricing with no hidden fees. Complex autoimmune and inflammatory condition treatments range from $25,000 to $50,000 USD, with a clear breakdown provided during your no-obligation consultation.
Chiang Mai offers a relaxed recovery environment with access to fresh, wholesome food options that support digestive healing. The warm climate and low-stress setting complement the treatment protocol.
Structured follow-up at 1, 3, 6, and 12 months via secure video consultation with inflammatory marker tracking (CRP, faecal calprotectin) ensures your progress is monitored objectively long after you return home.
Alternatives to surgery for Crohn's disease
Compare stem cell therapy with conventional treatment options for cost, recovery, and risk.
| Factor | Stem Cell Therapy | Conventional / Surgery |
|---|---|---|
| Typical Cost (Thailand) | $25,000 - $50,000 | $15,000 - $40,000 (bowel resection) |
| Recovery Time | Minimal downtime (varies by protocol) | 4-8 weeks post-surgical recovery |
| Invasiveness | Minimally invasive intravenous infusion | Major abdominal surgery / ongoing biologics |
| Hospital Stay | Varies by protocol | 5-10 days inpatient (surgery) or ongoing infusions |
| Risk Level | Low (cell-based, minimal side effects) | Moderate-High (surgical complications, biologic side effects) |
| Return to Normal Activity | Varies by protocol | 4-8 weeks (surgery) or ongoing treatment burden |
Treatment at Boston Health Longevity
$25,000 - $50,000
USD equivalent, personalised to your case
vs Home Country
$15,000 - $40,000 (bowel resection)
Internationally competitive pricing, same clinical standard
Costs are approximate. You receive a detailed, itemised quote after your initial assessment. Full pricing guide.
Wondering if you're a candidate?
Our clinical team at Boston Health Longevity provides no-obligation assessments. Honest advice even if therapy isn't right for you. Most patients receive a response within 24 hours.
Request AssessmentTrusted by international patients from 11+ countries worldwide
What to expect
Comprehensive remote consultation with review of gastroenterology records, endoscopy, and imaging
Arrive in Chiang Mai, accommodation and logistics support provided
Day 1: Clinical assessment, blood work, inflammatory markers, and nutritional evaluation
Day 2: Stem cell preparation and administration via intravenous infusion
Day 3-5: Monitoring, dietary guidance, and discharge with comprehensive care plan
Structured remote follow-up at 1, 3, 6, and 12 months with inflammatory marker tracking
Treatment stays range from 1 day to several weeks depending on your condition and protocol. Read the International Patient Guide →
Frequently Asked Questions
Can stem cell therapy cure Crohn's disease?
What evidence supports stem cell therapy for IBD?
Will I need to modify my current IBD medications?
How is this different from surgery for Crohn's?
Ready to explore crohn's disease treatment?
Our clinical team provides honest, no-obligation assessments. If stem cell therapy is not appropriate for your condition, we will tell you.
Most patients receive their initial assessment within 24 hours.
Submit Your Case
Share your medical history and imaging for review.
Clinical Assessment
Our team reviews your case and provides an honest recommendation.
Treatment Plan
Receive a personalised plan with transparent pricing.
Other conditions we treat
Related treatments & resources
Conditions We Treat
- Lupus
- Psoriasis
- Metabolic Syndrome
- Microvascular Dysfunction
- Muscle Strains & Tears
- Alzheimer's & Dementia
International Patients
Medical Disclaimer
The information on this page is for educational purposes only and does not constitute medical advice. Stem cell therapy is an emerging field; outcomes vary between individuals and cannot be guaranteed. No claims of cure or specific results are made. Always consult with a qualified healthcare provider before making treatment decisions. Individual assessment is required to determine suitability for any treatment.
Take the first step
Request a no-obligation assessment for crohn's disease treatment at Boston Health Longevity in Chiang Mai.
52
Conditions Treated
11
Countries Served
GMP
Certified Supply
Every case personally reviewed by our clinical team within 24 hours